{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:50:29Z","timestamp":1794563429624,"version":"4.9.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ijantimicag.2005.11.004","type":"journal-article","created":{"date-parts":[[2006,1,20]],"date-time":"2006-01-20T12:41:51Z","timestamp":1137760911000},"page":"87-96","source":"Crossref","is-referenced-by-count":110,"title":["Community-acquired methicillin-resistant Staphylococcus aureus infections"],"prefix":"10.1016","volume":"27","author":[{"given":"Helen C.","family":"Maltezou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Giamarellou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2005.11.004_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3201\/eid0702.010204","article-title":"The changing epidemiology of Staphylococcus aureus?","volume":"7","author":"Chambers","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1086\/345436","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors","volume":"36","author":"Salgado","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/427701","article-title":"Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic and therapeutic Odyssey","volume":"40","author":"Deresinski","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/322693","article-title":"Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996\u20131998","volume":"33","author":"Naimi","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/01.inf.0000131981.67342.c4","article-title":"Emergence of community-acquired methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee children's hospital","volume":"23","author":"Buckingham","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib7","first-page":"707","article-title":"Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus\u2014Minnesota and North Dakota, 1997\u20131999","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3201\/eid0806.010313","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus, Finland","volume":"8","author":"Salmenlinna","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib9","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3201\/eid0908.030089","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton\u2013Valentine leukocidin genes: worldwide emergence","volume":"9","author":"Vandenesch","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/342576","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton\u2013Valentine leukocidin","volume":"35","author":"Dufour","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib11","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1086\/383247","article-title":"Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton\u2013Valentine leukocidin during a furunculosis outbreak in rural Alaska","volume":"189","author":"Baggett","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1086\/378277","article-title":"Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates","volume":"37","author":"Mongkolrattanothai","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib13","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1542\/peds.113.4.e347","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children","volume":"113","author":"Dietrich","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1086\/323459","article-title":"Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in four Metropolitan Connecticut areas, 1998","volume":"184","author":"Morin","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.inf.0000151107.29132.70","article-title":"Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas","volume":"24","author":"Avalos Mishaan","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jama.286.10.1201","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community","volume":"286","author":"Groom","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib17","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/JCM.37.9.2858-2862.1999","article-title":"Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak","volume":"37","author":"O\u2019Brien","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3201\/eid1103.040470","article-title":"Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit","volume":"11","author":"Regev-Yochay","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/379022","article-title":"Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women","volume":"37","author":"Saiman","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1086\/502234","article-title":"Transmission of methicillin-resistant Staphylococcus aureus in the Neonatal Intensive Care Unit from a patient with community-acquired disease","volume":"24","author":"Eckhardt","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib21","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(02)08713-5","article-title":"Genome and virulence determinants of high virulence community-acquired methicillin-resistant Staphylococcus aureus","volume":"359","author":"Baba","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00001432-200304000-00007","article-title":"Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus\u2014an emerging problem for the management of skin and soft tissue infections","volume":"16","author":"Eady","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib23","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/JCM.40.11.4289-4294.2002","article-title":"Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community","volume":"40","author":"Okuma","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/33.1.7","article-title":"Molecular aspects of methicillin resistance in Staphylococcus aureus","volume":"33","author":"de Lencastre","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(02)07877-7","article-title":"Association between Staphylococcus aureus strains carrying gene for Panton\u2013Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients","volume":"359","author":"Gillet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib26","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1128\/JCM.42.5.2080-2084.2004","article-title":"Widespread skin and soft tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton\u2013Valentine leucocidin","volume":"42","author":"Diep","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/427148","article-title":"Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton\u2013Valentine leukocidin genes","volume":"40","author":"Francis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib28","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1128\/AAC.47.12.3926-3934.2003","article-title":"Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus","volume":"47","author":"Robinson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib29","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/S0140-6736(00)04832-7","article-title":"In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected]","volume":"357","author":"Wielders","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1086\/315695","article-title":"Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community","volume":"182","author":"Shopsin","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1086\/502230","article-title":"Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission","volume":"24","author":"Jernigan","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1086\/502223","article-title":"Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus in an outpatient clinic population","volume":"24","author":"Jernigan","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1017\/S0950268802007434","article-title":"Staphylococcus aureus nasal carriage in the community: a survey from central Italy","volume":"129","author":"Zanelli","year":"2002","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/10766290152652783","article-title":"Low prevalence of methicillin-resistant strains among Staphylococcus aureus colonizing young and healthy members of the community in Portugal","volume":"7","author":"Sa-Leao","year":"2001","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib35","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1542\/peds.113.6.1735","article-title":"The changing face of pleural empyemas in children: epidemiology and management","volume":"113","author":"Schultz","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib36","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1086\/423965","article-title":"Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers","volume":"39","author":"Ellis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006454-200105000-00023","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus and intrafamily spread of pustular disease","volume":"20","author":"Faden","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib38","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(95)91605-9","article-title":"Methicillin-resistant Staphylococcus aureus in the community","volume":"346","author":"Pate","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib39","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/archpedi.153.8.864","article-title":"Methicillin-resistant Staphylococcus aureus carriage in a child-care center following a case of disease","volume":"153","author":"Shahin","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/517478","article-title":"Methicillin-resistant Staphylococcus aureus in two child care centers","volume":"178","author":"Adcock","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib41","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3201\/eid1005.030604","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus among military recruits","volume":"10","author":"Zinderman","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib42","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid0809.020300","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities","volume":"8","author":"Borer","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib43","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3201\/eid1104.041094","article-title":"Recurring methicillin-resistant Staphylococcus aureus infections in a football team","volume":"11","author":"Nguyen","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib44","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/archinte.158.8.895","article-title":"Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community","volume":"158","author":"Lindenmayer","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib45","first-page":"88","article-title":"Outbreaks of community-associated methicillin-resistant Staphylococcus aureus infections. Los Angeles County, 2002\u20132003","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3201\/eid0801.010174","article-title":"An outbreak of community-acquired food-borne illness caused by methicillin-resistant Staphylococcus aureus","volume":"8","author":"Jones","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib47","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib48","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1542\/peds.2004-2300","article-title":"Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus","volume":"115","author":"Gonzalez","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib49","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1007\/s00134-003-1918-5","article-title":"Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton\u2013Valentine leukocidin-secreting Staphylococcus aureus","volume":"29","author":"Boussaud","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib50","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1128\/JCM.42.12.5673-5680.2004","article-title":"Emergence and spread of community-associated methicillin-resistant Staphylococcus aureus in rural Wisconsin, 1989 to 1999","volume":"42","author":"Stemper","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib51","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/426894","article-title":"Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned?","volume":"40","author":"Lewis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib52","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jac\/44.4.581","article-title":"Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?","volume":"44","author":"Panagea","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib53","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1128\/JCM.42.6.2777-2779.2004","article-title":"Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital","volume":"42","author":"Schreckenberger","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib54","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/377501","article-title":"Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro","volume":"37","author":"Siberry","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jac\/48.2.315","article-title":"Clindamycin treatment of Staphylococcus aureus expressing clindamycin resistance","volume":"48","author":"Drinkovic","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib56","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim\u2013sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","author":"Markowitz","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib57","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1345\/aph.1D156","article-title":"Trimethoprim\/sulfamethoxazole for treatment of severe Staphylococcus aureus infections","volume":"38","author":"Adra","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib58","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/jac\/45.6.763","article-title":"Expression of resistance to strains of methicillin-resistant Staphylococcus aureus","volume":"45","author":"Trzcinski","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jac\/47.2.239","article-title":"Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates","volume":"47","author":"Schmitz","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib60","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0924-8579(03)00006-2","article-title":"Emergence of phenotypic resistance to ciprofloxacin and levofloxacin in methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains","volume":"21","author":"Limoncu","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib61","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3201\/eid0911.030284","article-title":"Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients","volume":"9","author":"Weber","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijantimicag.2004.03.009","article-title":"Are the new quinolones appropriate treatment for community-acquired methicillin-resistant Staphylococcus aureus?","volume":"24","author":"Shopsin","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jac\/dkh076","article-title":"Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells","volume":"53","author":"Krut","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib64","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1128\/AAC.44.11.3229-3231.2000","article-title":"Development of resistance to ciprofloxacin, rifampin and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates","volume":"44","author":"Schmitz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib65","unstructured":"McKinnon PS, Lodise Jr TP, Rybak MJ. Impact of initial treatment with vancomycin versus a beta-lactam on outcomes and costs of methicillin-susceptible Staphylococcus aureus bacteremia (MSSAB). In: Program and abstracts of the 40th Annual Meeting of the Infectious Diseases Society of America; Chicago, IL; 24\u201327 October 2002 [Abstract 579]."},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib66","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1128\/AAC.47.10.3040-3045.2003","article-title":"Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods","volume":"47","author":"Liu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib67","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/381093","article-title":"Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus","volume":"38","author":"Charles","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib68","first-page":"902","article-title":"Vancomycin-resistant Staphylococcus aureus\u2014Pennsylvania, 2002","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib69","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0025-7125(16)30042-6","volume":"79","author":"Shea","year":"1995","journal-title":"Med Clin North Am"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2005.11.004_bib70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1469-0691.2005.01141.x","article-title":"The need for new therapeutic agents: what is the pipeline?","volume":"11","author":"Shah","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib71","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1128\/AAC.48.12.4665-4672.2004","article-title":"Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin in an in vitro pharmacodynamic model","volume":"48","author":"La Plante","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib72","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/13543784.13.9.1159","article-title":"Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections","volume":"13","author":"Eisenstein","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib73","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib74","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/AAC.46.5.1475-1480.2002","article-title":"Intrapulmonary pharmacokinetics of linezolid","volume":"46","author":"Conte","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib75","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00134-003-2135-y","article-title":"Linezolid in VAP by MRSA: a better choice?","volume":"30","author":"Ioanas","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib76","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/340353","article-title":"Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"34","author":"Stevens","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib77","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.inf.0000078160.29072.42","article-title":"Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children","volume":"22","author":"Kaplan","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib78","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/367662","article-title":"Quinupristin\u2013dalfopristin and linezolid: evidence and opinion","volume":"36","author":"Eliopoulos","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib79","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1164\/ajrccm.161.3.9904115","article-title":"Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin\/dalfopristin versus vancomycin","volume":"161","author":"Fagon","year":"2000","journal-title":"Am J Resp Crit Care Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2005.11.004_bib80","first-page":"1027","article-title":"Single dose pharmacokinetics (PK) of televancin (TLV) in healthy elderly subjects (abstract 902)","volume":"1","author":"Duchin","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib81","unstructured":"Giamarellou H, O\u2019Riordan W, Harris H, Owen S, Porter S, Loutit J. Phase 3 trial comparing 3\u20137 days of oritavancin vs. 10\u201314 days of vancomycin\/cephalexin in the treatment of patients with complicated skin and skin structure infections (cSSSI). In: Program and abstracts of the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 2003 [Abstract L-739a]."},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib82","first-page":"206","article-title":"Novel cephalosporins for the treatment of MRSA infections","volume":"3","author":"Glinka","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib83","unstructured":"Fetterly GJ, Ong C, Bhavnani SM, et al. Characterization of oritavancin (ORI) pharmacokinetics (PK) in plasma and blister fluid in normal healthy volunteers. In: Program and abstracts of the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 2003 [Abstract A-18]."},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib84","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/379015","article-title":"Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections","volume":"37","author":"Seltzer","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2005.11.004_bib85","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1086\/431672","article-title":"Tigecycline: a new glycylcycline for treatment of serious infections","volume":"41","author":"Noskin","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2005.11.004_bib86","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/431675","article-title":"The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin\u2013aztreonam","volume":"41","author":"Ellis-Grosse","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib87","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/47.2.153","article-title":"Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus","volume":"47","author":"Wichelhaus","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib88","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1016\/j.bmcl.2003.07.023","article-title":"Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria","volume":"13","author":"Schneider","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib89","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/AAC.40.6.1376","article-title":"Antimicrobial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone","volume":"40","author":"Locher","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib90","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1128\/AAC.47.3.1148-1150.2003","article-title":"Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents","volume":"47","author":"Hoellman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib91","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jac\/dkg162","article-title":"In vitro development of resistance to a novel fluoroquinolone, DW286, in methicillin-resistant Staphylococcus aureus clinical isolates","volume":"51","author":"Kim","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib92","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dkh242","article-title":"ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model","volume":"54","author":"Firsov","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib93","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1128\/AAC.44.8.2086-2092.2000","article-title":"Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria","volume":"44","author":"Friedrich","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib94","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1128\/AAC.47.11.3613-3615.2003","article-title":"In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood","volume":"47","author":"von Eiff","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib95","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/380909","article-title":"Neutralization of Staphylococcus aureus Panton\u2013Valentine leukocidin by intravenous immunoglobulin in vitro","volume":"189","author":"Gauduchon","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib96","unstructured":"US National Institutes of Health. Clinical trial: safety and behaviour of S. aureus immune globulin intravenous (human) [Altastaph] in patients with S. aureus bacteremia and continuing fever. Available at: http:\/\/www.clinicaltrials.gov\/ct\/gui\/show\/NCT00063089?amp;order=5 [accessed 6 January 2005]."},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib97","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.1128\/IAI.71.12.6864-6870.2003","article-title":"Characterisation of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A","volume":"71","author":"Hall","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib98","unstructured":"Inhibitex. Product candidates: Aurexis\u00ae. Available at: http:\/\/www.inhibitex.com\/product\/aurexis.asp [accessed 6 January 2005]."},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib99","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa011297","article-title":"Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis","volume":"346","author":"Shinefield","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib100","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ahj.2004.01.012","article-title":"Staphylococcus aureus types 5 and 8 capsular polysaccharide\u2013protein conjugate vaccines","volume":"147","author":"Robbins","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib101","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jac\/dkg127","article-title":"Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance","volume":"51","author":"Upton","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.11.004_bib102","first-page":"1","article-title":"Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC\/SHEA\/APIC\/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America\/Association for Professionals in Infection Control\/Infectious Diseases Society of America","volume":"51","author":"Boyce","year":"2002","journal-title":"MMWR Recomm Rep"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790500333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790500333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T06:29:13Z","timestamp":1586672953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485790500333X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S092485790500333X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.11.004","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}